Premium
Antioxidant treatment ameliorates diabetes‐induced dysfunction of the vas deferens in a rat model
Author(s) -
Tsounapi P.,
Honda M.,
Dimitriadis F.,
Shimizu S.,
Shiomi T.,
Hikita K.,
Saito M.,
Tomita S.,
Sofikitis N.,
Takenaka A.
Publication year - 2018
Publication title -
andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.633
H-Index - 59
eISSN - 1439-0272
pISSN - 0303-4569
DOI - 10.1111/and.12795
Subject(s) - streptozotocin , oxidative stress , medicine , diabetes mellitus , endocrinology , vas deferens , testosterone (patch) , malondialdehyde , male infertility , antioxidant , sperm , erectile dysfunction , infertility , biology , andrology , pregnancy , biochemistry , genetics
Summary Diabetes mellitus ( DM ) affects the male ejaculatory function. This study was designed to evaluate the role of oxidative stress in the development of diabetes‐induced dysfunction of vas deferens ( VD ) in the rat. DM was induced by streptozotocin in 40 male Wistar rats. Subsequently, the diabetic animals were divided into three groups: DM group, DM + Eda group and DM + Tau group. These groups were administered saline, edaravone and taurine, respectively, daily for 4 weeks. Another group of ten rats served as a control group. DM was diagnosed in the 40 streptozotocin‐injected rats. DM significantly reduced the VD weight. Additionally, DM induced in vitro VD hypercontractility, VD histological abnormalities and increased the serum and VD tissue concentration of malondialdehyde. VD immunohistochemistry revealed overexpression of three markers of oxidative stress. DM significantly reduced serum testosterone levels. No live birth was documented in all DM rats in mating experiments. Antioxidants significantly improved all the aforementioned parameters, except the testosterone levels. This study indicates a deleterious impact of DM ‐induced oxidative stress on VD histological and functional features. Antioxidant treatment may provide an adjunct tool to alleviate ejaculatory disorders for male patients with type 1 diabetes.